-
Anti-Epileptic Drugs Associated With Birth Defects And Fetal Death
Study Looks At Depakote, Dilantin, Tegretol, And Lamictal An August 8, 2006 article in the Los Angeles Times (LA Times) reports about a recent study involving four popular epilepsy drugs which found that one…
-
Natrecor: An Example Of How Drug Companies Might Influence Doctors
"Off-label" Prescribing Is At Center Of Ongoing Natrecor Controversy A recent article of interest is "The Rise And Fall Of Natrecor For Congestive Heart Failure: Implications For Drug Policy", by Aaron S. Kesselheim, Michael…
-
Ketek Allegedly “More Toxic Than Most Other Drugs”
Dr. David Graham At FDA Wants An "Immediate Withdrawal" Of Ketek On the morning of July 19, 2006 a National Public Radio (NPR) news piece about Ketek brought our attention back to this increasingly…
-
Recent Developments In The Federal Court Vioxx MDL Litigation
<p><strong><span style="font-size: 1.2em;">UPDATE: Global Settlement Offer Made By Merck To End Vioxx Litigation According To November 9, 2007 News Reports</span></strong></p> <p><strong><span style="font-size: 1.2em;"><p><a href="http://www.nytimes.com/2007/11/09/business/09merck.html?_r=1&th&emc=th&oref=slogin">Merck Agrees to Settle Vioxx Suits for $4.85 Billion </a>(NY Times)</p>…
-
Drug Errors Occur At All Points In Medication Process
Implementation Of Monitoring Programs Can Reduce And Prevent Mistakes In June 2006 the medical journal Quality & Safety in Healthcare published an article, "Computer based medication error reporting: insights and implications", that demonstrated drug…
Free. Confidential. No Obligation.
Free Case Evaluation
We encourage you to submit a Drug Injury Case Evaluation Form online – it is free, confidential, and there is no obligation. Or, if you prefer, call 910-256-2971 to speak directly to attorney Tom Lamb about a possible drug injury lawsuit. Either way, you will get Mr. Lamb’s impressions about your possible case, and the benefit of his over 25 years of experience handling drug injury cases.
About the Law Offices of Thomas J. Lamb
The Law Offices of Thomas J. Lamb has been representing patients and their families in drug injury lawsuits throughout the country for more than 25 years.
Drug injury cases involve personal injury claims or wrongful death claims filed on behalf of people who experienced unwanted side effects or a serious adverse reaction caused by a prescription drug. Some unsafe drugs have been the subject of government warnings or a drug recall, while other drugs remain on the market with black box warnings and continue to be prescribed by doctors today.
Given the many years of experience attorney Tom Lamb has handling these types of lawsuits, we know drug injury cases deserve special attention.
Drug injury claims have a personal aspect that must be appreciated and respected by the lawyer handling your case. At our firm, it is not class actions. Rather, we always file an individual case lawsuit. With this approach, you will get personal attention, and the lawsuit is only about your specific case. An individual lawsuit for your drug injury case is better from start to finish.
The Law Offices of Thomas J. Lamb will handle your drug injury case competently and professionally, as well as with genuine care and understanding. As our client, your email inquiries are responded to promptly, and telephone calls are always returned without delay if we are not available immediately.
We encourage you to submit a Drug Injury Case Evaluation Form – it is free, confidential, and there is no obligation. Or, if you prefer, you can call 910-256-2971 and speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, or some other lawyer — about your case based on his many years of experience.
In closing, at the Law Offices of Thomas J. Lamb, we understand that you have options when it comes to finding the right law firm to handle your case.
Please know that we look forward to working on your behalf.
Tom Lamb
Handling drug injury cases since 1999